Ignite Creation Date:
2024-10-25 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06608147
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-09-19
Brief Title:
MOLyF Bone Marrow and Follicular Lymphoma
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Bone Marrow and Follicular Lymphoma
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MOLyF
Brief Summary:
This is a prospective single-center study designed to assess potential differences in cell composition between bone marrows of patients with follicular lymphoma and those from control subjects
Follicular lymphoma is the most common indolent lymphoma It is characterised by systematic relapses and bone marrow dissemination in 70 of patients at the time of diagnosis
Although relapses are thought to be related to refractory tumour cells nested in a supportive microenvironment in the bone marrow the mechanisms involved are poorly understood
To study the specificities of the bone marrow of patients with follicular lymphoma It is necessary to compare them with control samples
This study takes advantage of surgeries involving sternotomies to recover lost bone marrow and establish a bone marrow bank of patients without hematological disease
This bank will be used to set up control cohorts for other clinical trials involving patients with follicular lymphoma
Follicular lymphoma is the most common indolent lymphoma It is characterised by systematic relapses and bone marrow dissemination in 70 of patients at the time of diagnosis
Although relapses are thought to be related to refractory tumour cells nested in a supportive microenvironment in the bone marrow the mechanisms involved are poorly understood
To study the specificities of the bone marrow of patients with follicular lymphoma It is necessary to compare them with control samples
This study takes advantage of surgeries involving sternotomies to recover lost bone marrow and establish a bone marrow bank of patients without hematological disease
This bank will be used to set up control cohorts for other clinical trials involving patients with follicular lymphoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None